{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:15:07Z","timestamp":1788369307905,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T00:00:00Z","timestamp":1479513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Israel Science Fundation","award":["1985\/13"],"award-info":[{"award-number":["1985\/13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10689-016-9951-z","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T03:11:21Z","timestamp":1479525081000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Recurrent TP53 missense mutation in cancer patients of Arab descent"],"prefix":"10.1007","volume":"16","author":[{"given":"Aviad","family":"Zick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Kadouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frohlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Hamburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morasha","family":"Plaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilat","family":"Avital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Breuier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firase","family":"Elian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzam","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,19]]},"reference":[{"issue":"28","key":"9951_CR1","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","volume":"107","author":"T Walsh","year":"2010","unstructured":"Walsh T et al (2010) Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 107(28):12629\u201312633","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9951_CR2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","volume":"357","author":"M Robson","year":"2007","unstructured":"Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357(2):154\u2013162","journal-title":"N Engl J Med"},{"issue":"23","key":"9951_CR3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243\u20132257","journal-title":"N Engl J Med"},{"issue":"21","key":"9951_CR4","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345\u20132352","journal-title":"J Clin Oncol"},{"issue":"18","key":"9951_CR5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","volume":"329","author":"CC Harris","year":"1993","unstructured":"Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329(18):1318\u20131327","journal-title":"N Engl J Med"},{"issue":"2","key":"9951_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa070608","volume":"357","author":"G Rennert","year":"2007","unstructured":"Rennert G et al (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(2):115\u2013123","journal-title":"N Engl J Med"},{"issue":"1","key":"9951_CR7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/301924","volume":"63","author":"I Lerer","year":"1998","unstructured":"Lerer I et al (1998) The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet 63(1):272\u2013274","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9951_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10689-010-9395-9","volume":"10","author":"M Sagi","year":"2011","unstructured":"Sagi M et al (2011) Two BRCA1\/2 founder mutations in Jews of Sephardic origin. Fam Cancer 10(1):59\u201363","journal-title":"Fam Cancer"},{"key":"9951_CR9","first-page":"31","volume":"3","author":"A Zick","year":"2016","unstructured":"Zick A, Cohen S, Hamburger T, Goldberg Y, Zvi N, Sagi M, Peretz T (2016) A BRCA1 frame shift mutation in women of kurdish Jewish descent. Open Med J 3:31\u201336","journal-title":"Open Med J"},{"issue":"6","key":"9951_CR10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cge.12530","volume":"87","author":"Y Goldberg","year":"2015","unstructured":"Goldberg Y et al (2015) Genetic features of Lynch syndrome in the Israeli population. Clin Genet 87(6):549\u2013553","journal-title":"Clin Genet"},{"issue":"2","key":"9951_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10689-009-9298-9","volume":"9","author":"Y Goldberg","year":"2010","unstructured":"Goldberg Y et al (2010) An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Fam Cancer 9(2):141\u2013150","journal-title":"Fam Cancer"},{"issue":"7","key":"9951_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.clon.2007.05.001","volume":"19","author":"A Salmon","year":"2007","unstructured":"Salmon A et al (2007) Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline \u2018de-novo\u2019 TP53 mutation. Clin Oncol (R Coll Radiol) 19(7):490\u2013493","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"9951_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2407-7-14","volume":"7","author":"L Kadouri","year":"2007","unstructured":"Kadouri L et al (2007) A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer 7:14","journal-title":"BMC Cancer"},{"key":"9951_CR14","unstructured":"Registry INC (2016) Breast cancer, invasive (Gender and Subpopulation)\u2014Cancer Incidence trends 1980\u20132013. https:\/\/www.health.gov.il\/UnitsOffice\/HD\/ICDC\/ICR\/CancerIncidence\/Pages\/Breast_Invasive.aspx"},{"issue":"10","key":"9951_CR15","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1016\/S1470-2045(13)70165-7","volume":"14","author":"L Chouchane","year":"2013","unstructured":"Chouchane L, Boussen H, Sastry KS (2013) Breast cancer in Arab populations: molecular characteristics and disease management implications. Lancet Oncol 14(10):e417\u2013e424","journal-title":"Lancet Oncol"},{"issue":"1","key":"9951_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjsurg.2003.11.039","volume":"188","author":"A Nissan","year":"2004","unstructured":"Nissan A et al (2004) Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg 188(1):62\u201367","journal-title":"Am J Surg"},{"issue":"4","key":"9951_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1634\/theoncologist.2014-0364","volume":"20","author":"NS Saghir El","year":"2015","unstructured":"El Saghir NS et al (2015) BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. Oncologist 20(4):357\u2013364","journal-title":"Oncologist"},{"issue":"2","key":"9951_CR18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-010-1217-0","volume":"127","author":"Y Laitman","year":"2011","unstructured":"Laitman Y et al (2011) Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat 127(2):489\u2013495","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9951_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-015-3662-2","volume":"155","author":"T Yablonski-Peretz","year":"2016","unstructured":"Yablonski-Peretz T et al (2016) Screening for germline mutations in breast\/ovarian cancer susceptibility genes in high-risk families in Israel. Breast Cancer Res Treat 155(1):133\u2013138","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"9951_CR20","first-page":"2984","volume":"52","author":"D Sidransky","year":"1992","unstructured":"Sidransky D et al (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52(10):2984\u20132986","journal-title":"Cancer Res"},{"issue":"11","key":"9951_CR21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1214091","volume":"368","author":"PY Wang","year":"2013","unstructured":"Wang PY et al (2013) Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 368(11):1027\u20131032","journal-title":"N Engl J Med"},{"issue":"16","key":"9951_CR22","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1038\/sj.onc.1207516","volume":"23","author":"EA Slee","year":"2004","unstructured":"Slee EA, O\u2019Connor DJ, Lu X (2004) To die or not to die: how does p53 decide? Oncogene 23(16):2809\u20132818","journal-title":"Oncogene"},{"issue":"15","key":"9951_CR23","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/sj.onc.1202565","volume":"18","author":"PD Smith","year":"1999","unstructured":"Smith PD et al (1999) Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18(15):2451\u20132459","journal-title":"Oncogene"},{"issue":"3","key":"9951_CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1541-7786.MCR-10-0496","volume":"9","author":"P Monti","year":"2011","unstructured":"Monti P et al (2011) Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. Mol Cancer Res 9(3):271\u2013279","journal-title":"Mol Cancer Res"},{"issue":"2","key":"9951_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1590\/1678-4685-gmb-2014-0343","volume":"39","author":"KC Andrade","year":"2016","unstructured":"Andrade KC et al (2016) Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation. Genet Mol Biol 39(2):199\u2013202","journal-title":"Genet Mol Biol"},{"issue":"6","key":"9951_CR26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","volume":"12","author":"A Villani","year":"2011","unstructured":"Villani A et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12(6):559\u2013567","journal-title":"Lancet Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-016-9951-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:00:59Z","timestamp":1498348859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-016-9951-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,19]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["9951"],"URL":"https:\/\/doi.org\/10.1007\/s10689-016-9951-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,19]]}}}